Profile data is unavailable for this security.
About the company
Y.S.P. Southeast Asia Holding Berhad is a Malaysia-based healthcare company involved mainly in the trading and manufacturing of pharmaceutical products, particularly generic drugs. The Company, and its subsidiaries, carries a wide range of products, including pharmaceuticals, over the counter (OTC), veterinary and aquatic products, traditional complementary medicine (TCM), and food supplements in ASEAN, the Middle East, Africa, Australia, and New Zealand. The Company's segments include Manufacturing, Trading, and Investment Holding. The Manufacturing segment is engaged in the manufacturing of pharmaceutical products. The Trading segment is involved in the import, export and trading of various kinds of pharmaceutical, traditional herbal and veterinary products. The Investment Holding segment is involved in investment holding activities. Its subsidiaries include Y.S.P. (Cambodia) Pte. Ltd., Alpha Active Industries Sdn. Bhd., Y.S.P. Industries Vietnam Co., Ltd., and others.
- Revenue in MYR (TTM)364.55m
- Net income in MYR31.15m
- Incorporated2001
- Employees519.00
- LocationYSP Southeast Asia Holding Bhd16th Floor, Plaza VADSNo. 1, Jalan Tun Mohd FuadTaman Tun Dr. IsmailKUALA LUMPUR 60000MalaysiaMYS
- Phone+60 377276390
- Fax+60 377276701
- Websitehttps://www.yspsah.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| bluebird bio Inc | 244.20m | -1.39bn | 324.57m | 375.00 | -- | 1.38 | -- | 1.33 | -2.19 | -2.19 | 0.3574 | 0.2733 | 0.0909 | 3.21 | -- | 146,400.00 | -51.54 | -34.75 | -80.31 | -40.84 | -37.34 | -124.35 | -567.29 | -5,770.41 | 0.5712 | -19.81 | 0.7827 | -- | 720.04 | -11.58 | 8.00 | -- | -30.47 | -- |
| Curatis Holding AG | 0.00 | -247.89m | 328.55m | 15.00 | -- | -- | -- | -- | -169.12 | -169.12 | 0.00 | -1.09 | 0.00 | -- | -- | -- | -697.16 | -483.12 | -821.63 | -658.52 | -- | -- | -- | -397.95 | -- | -241.72 | -- | -- | -- | -- | -42.17 | -- | -- | -- |
| CASI Pharmaceuticals Inc | 102.75m | -121.01m | 330.83m | 176.00 | -- | 8.24 | -- | 3.22 | -2.03 | -2.03 | 1.72 | 0.6731 | 0.3577 | 0.8917 | 2.39 | 131,250.00 | -41.56 | -34.75 | -62.38 | -46.91 | 56.81 | 55.98 | -116.17 | -153.72 | 2.36 | -- | 0.6718 | -- | -21.41 | -- | 34.27 | -- | 14.65 | -- |
| Ohki Healthcare Holdings Co Ltd | 7.28bn | 36.59m | 331.77m | 632.00 | 8.84 | 0.3764 | 7.65 | 0.0456 | 93.26 | 93.26 | 18,553.59 | 2,189.15 | 1.82 | 9.59 | 3.36 | 402,672,500.00 | 0.875 | 1.85 | 3.76 | 8.42 | 4.99 | 6.16 | 0.481 | 0.7178 | 0.8641 | -- | 0.2547 | 13.92 | 9.92 | 5.30 | 1.28 | 1.51 | -5.34 | 5.92 |
| YSP Southeast Asia Holding Bhd | 364.55m | 31.15m | 333.34m | 519.00 | 10.70 | 0.8376 | 7.03 | 0.9144 | 0.2196 | 0.2196 | 2.57 | 2.81 | 0.68 | 1.52 | 5.43 | -- | 5.89 | 5.83 | 7.17 | 6.83 | 44.21 | 42.57 | 8.65 | 8.46 | 2.67 | 56.19 | 0.1143 | 39.47 | 6.21 | 4.22 | 8.27 | 4.22 | 4.29 | 2.71 |
| IND Swift Laboratories Ltd | 528.85m | 213.21m | 335.60m | 47.00 | 1.57 | -- | 1.43 | 0.6346 | 68.53 | 68.53 | 170.41 | -- | -- | -- | -- | 213,559,000.00 | -- | 5.00 | -- | 6.13 | 47.54 | 41.12 | 40.36 | 8.52 | -- | 4.68 | -- | 0.00 | 6.10 | 11.10 | 784.44 | 70.82 | 23.60 | -- |
| 3D Medicines Inc | 300.54m | -276.50m | 336.55m | 193.00 | -- | 0.6456 | -- | 1.12 | -2.06 | -2.06 | 2.20 | 3.53 | 0.3746 | 4.94 | 5.79 | 2,655,131.00 | -37.27 | -- | -50.88 | -- | 91.97 | -- | -99.50 | -- | 2.56 | -- | 0.2517 | -- | 11.91 | -- | 48.78 | -- | -- | -- |
| Journey Medical Corp | 345.53m | 3.75m | 339.10m | 58.00 | 51.00 | 9.07 | 18.59 | 0.9814 | -0.0131 | -0.0131 | 3.91 | 0.5642 | 1.15 | 2.36 | 5.71 | 1,339,328.00 | 1.25 | -- | 5.17 | -- | 66.79 | -- | 1.09 | -- | 1.08 | 2.00 | 0.6682 | -- | 7.48 | -- | 87.00 | -- | -- | -- |
| Vita Life Sciences Limited | 227.66m | 27.15m | 339.50m | 124.00 | 12.18 | 2.42 | 11.90 | 1.49 | 0.1717 | 0.1717 | 1.44 | 0.865 | 1.29 | 2.33 | 6.94 | -- | 15.37 | 15.25 | 21.18 | 21.99 | 58.48 | 60.90 | 11.90 | 11.71 | 2.18 | -- | 0.0088 | 39.05 | 10.88 | 12.50 | 28.18 | 30.07 | 12.15 | 19.14 |
| OptiNose Inc | 336.59m | -138.55m | 340.16m | 132.00 | -- | -- | -- | 1.01 | -0.2216 | -0.2216 | 0.5416 | -0.2725 | 0.6512 | 0.7659 | 2.96 | 573,272.80 | -26.80 | -48.25 | -- | -98.95 | 90.21 | 86.96 | -41.16 | -131.66 | 0.7198 | -1.61 | 1.48 | -- | -6.93 | 58.64 | 52.58 | -- | -27.96 | -- |
| Haemato AG | 1.23bn | 45.16m | 343.49m | 78.00 | 7.60 | 0.4883 | 6.79 | 0.2803 | 1.84 | 1.84 | 50.10 | 28.67 | 1.47 | 9.80 | 12.48 | 3,343,690.00 | 5.41 | 2.01 | 6.45 | 2.70 | 7.56 | 8.42 | 3.68 | 1.21 | 1.66 | -- | 0.0203 | 157.20 | -12.95 | -3.03 | 25.39 | 3.32 | -5.75 | -16.74 |
| Holder | Shares | % Held |
|---|---|---|
| Public Mutual Bhd.as of 29 Mar 2024 | 805.00k | 0.57% |
| Phillip Capital Management Sdn. Bhd.as of 29 Mar 2024 | 461.00k | 0.33% |
